文献引用 (180)
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.
靶向从头嘧啶合成会使 PARP 抑制剂耐药的卵巢癌对铜介导的 ATR 失活变得脆弱。
PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites.
PARPi 结合纳米颗粒 LIN28B siRNA 用于治疗恶性腹水。
Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity.
多组学分析和临床前模型实验表明,RAD51-IN-1 可增强安罗替尼的敏感性。
Arginine dependency in omental metastasis of epithelial ovarian cancer reveals a therapeutic vulnerability.
上皮性卵巢癌大网膜转移中精氨酸依赖性揭示了治疗上的脆弱性。
CBX2 phase-separation contributes to homologous recombination repair and drug resistance in ovarian cancer.
CBX2 相分离有助于卵巢癌的同源重组修复和耐药性。
FRY Mediates THP1-Driven Ovarian Cancer Invasion Through the PI3K/AKT Pathway.
FRY 通过 PI3K/AKT 通路介导 THP1 驱动的卵巢癌侵袭。
SCHEMBL4796824: a multifaceted antitumor agent targeting microtubule dynamics, DNA damage, and Wnt/β-catenin signaling in ovarian cancer cells.
SCHEMBL4796824:一种多方面的抗肿瘤药物,靶向卵巢癌细胞中的微管动力学、DNA损伤和Wnt/β-catenin信号传导。
The cyclin-dependent kinase inhibitor p27 facilitates chemosensitivity by promoting ferroptosis in epithelial ovarian cancer.
细胞周期蛋白依赖性激酶抑制剂 p27 通过促进上皮性卵巢癌细胞的铁死亡来增强化疗敏感性。
Multi-omics and network pharmacology reveal the mechanisms of Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang against pancreatic cancer.
多组学和网络药理学揭示了 Scutellaria barbata D.Don 和 Scleromitrion diffusum (Willd.) RJWang 抗胰腺癌的机制。
Irisin regulates lipid metabolism and ferroptosis in ovarian cancer cells by modulating the ALOX5-5-HETE-PD-L1 axis.
鸢尾素通过调节 ALOX5-5-HETE-PD-L1 轴来调节卵巢癌细胞的脂质代谢和铁死亡。
- 1
- 2
- 3
- 4
- 5
- 6
- 18